$GSK: 1st Trial Cures 18 of 18 Colon Cancers

NY Times headline: A Cancer Trial’s Unexpected Result: Remission in Every Patient

Subheadline: The study was small, and experts say it needs to be replicated. But for 18 people with rectal cancer, the outcome led to “happy tears.”


It was a small trial, just 18 rectal cancer patients, every one of whom took the same drug.

But the results were astonishing. The cancer vanished in every single patient, undetectable by physical exam, endoscopy, PET scans or M.R.I. scans.

Dr. Luis A. Diaz Jr. of Memorial Sloan Kettering Cancer Center, an author of a paper published Sunday in the New England Journal of Medicine describing the results, which were sponsored by the drug company GlaxoSmithKline, said he knew of no other study in which a treatment completely obliterated a cancer in every patient.


Disclosure: I bought an opening 1/3 slug in the pre-market. I can visualize what this will do on the healthy looking charts. Got in for $43.29 per share.


1) $GSK Hopeful news!

“I believe this is the first time this has happened in the history of cancer,” Dr. Diaz said.

“A complete remission in every single patient is “unheard-of” said Dr. Alan P. Venook, a colorectal cancer specialist at UCSF

2) $GSK daily was still in bullish crossover range end of day Friday, 3 MAY 22 +

Last pre-market trade was $43.25, which hints the open will be above the up trendline (after Friday’s close on it) and centered inside the secular bull flag pattern as well.

3) $GSK weekly and monthly charts: + +

These two charts show the bull channels $GSK has traded through since their respective bullish crossovers took place in Spring of 2021:

4) More from NYT link: “These rectal cancer patients had faced grueling treatments — chemotherapy, radiation and, most likely, life-altering surgery that could result in bowel, urinary and sexual dysfunction. Some would need colostomy bags.” (continued)
Peregrine Trader
5) (continued) "They entered the study thinking that, when it was over, they would have to undergo those procedures because no one really expected their tumors to disappear.



$GSK up for the day on 2x average volume. Here’s hoping tomorrow is more of the same.

1 Like